QDEL
QuidelOrtho Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$13.97
+0.29%Aug 17, 2026, 19:06 UTC
QuidelOrtho cut its 2026 outlook, citing deeper China and respiratory risks, while cash use and rising debt add pressure despite resilient core growth.
Source:Aug 6, 2026, 20:05 UTC
QuidelOrtho Corporation reported second quarter 2026 financial results with total revenue of $631 million, up 3% as reported and 2% in constant currency, driven by Labs and Point of Care growth.
Jun 27, 2026, 12:28 UTC
QuidelOrtho plans to sell its testing unit for $1.5 billion.
Source:Jun 23, 2026, 00:00 UTC
QuidelOrtho Corp appointed Micah Young as Chief Financial Officer, effective July 6, 2026.